Approval of Epidiolex Validates What Many CBD Users Already Knew

Medical Jane
By Nanette PorterJun 29, 2018, 8:15 am655 ptsHot
The FDA announced in a press release on Monday that it had approved the “first drug comprised of an active ingredient derived from marijuana to treat rare, severe forms of epilepsy.” Prior to this week, the U.S. Food and Drug Administration (FDA) had approved only three cannabinoid-based medicines. None of…

Read Article Share
Share Article
- email
- twitter
- facebook
- pocket
- reddit
- tumblr
- linkedin
- pinterest

Trending Today on NewsBudz

Built to Withstand: 5 Adaptations Cannabis Facilities Should Make for Corrosion Resistance 66

3 states increase cannabis levies as ideal tax rate remains elusive 63

Vireo Growth Refinances Senior Secured Debt Through $120M Loan 60

John Hopkins University Study: Cannabis Initiation Associated with Significant Reductions in Anxiety, Depression 58

Activists Celebrate 50 Years Of Marijuana Decriminalization In California 53

Cannabis Advertising and Social Media Influencers 52

Farmgate a step forward, but more changes needed to make it viable, say producers 44

Alabama’s Top Medical Marijuana Official Is ‘Very Hopeful’ Patients Could Finally Get Legal Access By The End Of 2025 39

About NewsBudz

NewsBudz is your go-to app for daily cannabis news, covering everything from medical marijuana breakthroughs to recreational cannabis trends and legalization updates.

Our platform aggregates content from over 30 top-tier cannabis news outlets to deliver a curated stream of the latest headlines, insights, and developments across the marijuana and hemp industries.

Whether you're interested in policy reform, health research, cannabis business, CBD, delta 9 products or lifestyle stories, NewsBudz keeps you informed and connected. Accessible on the web and mobile, NewsBudz makes it easy to explore, read, and share cannabis news anytime, anywhere.